These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26898568)

  • 1. Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.
    Song I; Weller S; Patel J; Borland J; Wynne B; Choukour M; Jerva F; Piscitelli S
    Eur J Clin Pharmacol; 2016 Jun; 72(6):665-70. PubMed ID: 26898568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.
    Song I; Borland J; Chen S; Guta P; Lou Y; Wilfret D; Wajima T; Savina P; Peppercorn A; Castellino S; Wagner D; Hosking L; Mosteller M; Rubio JP; Piscitelli SC
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1173-9. PubMed ID: 25146692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects.
    Ross LL; Song IH; Arya N; Choukour M; Zong J; Huang SP; Eley T; Wynne B; Buchanan AM
    BMC Infect Dis; 2016 Jul; 16():347. PubMed ID: 27450277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of pharmacokinetic interaction between rilpivirine and integrase inhibitors dolutegravir and GSK1265744.
    Ford SL; Gould E; Chen S; Margolis D; Spreen W; Crauwels H; Piscitelli S
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5472-7. PubMed ID: 23979733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjects.
    Zong J; Borland J; Jerva F; Wynne B; Choukour M; Song I
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19584. PubMed ID: 25394090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects.
    Song I; Mark S; Chen S; Savina P; Wajima T; Peppercorn A; Bala U; Geoffroy P; Piscitelli S
    Drug Alcohol Depend; 2013 Dec; 133(2):781-4. PubMed ID: 24018316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment.
    Weller S; Borland J; Chen S; Johnson M; Savina P; Wynne B; Wajima T; Peppercorn AF; Piscitelli SC
    Eur J Clin Pharmacol; 2014 Jan; 70(1):29-35. PubMed ID: 24096683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fosamprenavir-ritonavir on the pharmacokinetics of dolutegravir in healthy subjects.
    Song I; Borland J; Chen S; Peppercorn A; Wajima T; Piscitelli SC
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6696-700. PubMed ID: 25155604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin.
    Wang X; Cerrone M; Ferretti F; Castrillo N; Maartens G; McClure M; Boffito M
    Int J Antimicrob Agents; 2019 Aug; 54(2):202-206. PubMed ID: 31002950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prednisone on the pharmacokinetics of the integrase inhibitor dolutegravir.
    Song IH; Borland J; Chen S; Savina P; Peppercorn AF; Piscitelli S
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4394-7. PubMed ID: 23817375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects.
    Dooley KE; Sayre P; Borland J; Purdy E; Chen S; Song I; Peppercorn A; Everts S; Piscitelli S; Flexner C
    J Acquir Immune Defic Syndr; 2013 Jan; 62(1):21-7. PubMed ID: 23075918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
    Anderson MS; Khalilieh S; Yee KL; Liu R; Fan L; Rizk ML; Shah V; Hussaini A; Song I; Ross LL; Butterton JR
    Clin Pharmacokinet; 2017 Jun; 56(6):661-669. PubMed ID: 27699622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of CYP3A4 induction/inhibition on the pharmacokinetics of vilazodone in healthy subjects.
    Boinpally R; Gad N; Gupta S; Periclou A
    Clin Ther; 2014 Nov; 36(11):1638-49. PubMed ID: 25236915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjects.
    Patel P; Song I; Borland J; Chen S; Peppercorn A; Wajima T; Funaki T; Fujita N; Hughes J; Piscitelli S
    Antivir Ther; 2014; 19(3):229-33. PubMed ID: 24275098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of etravirine alone and with ritonavir-boosted protease inhibitors on the pharmacokinetics of dolutegravir.
    Song I; Borland J; Min S; Lou Y; Chen S; Patel P; Wajima T; Piscitelli SC
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3517-21. PubMed ID: 21555764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low- and High-Mineral-Content Water on the Tablet in Healthy Adults.
    Buchanan AM; Holton M; Conn I; Davies M; Choukour M; Wynne BR
    Clin Pharmacol Drug Dev; 2017 Nov; 6(6):577-583. PubMed ID: 28168828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics and safety of dolutegravir in healthy Japanese subjects].
    Wajima T; Koshiba T; Ohno K; Nishimura Y; Kobayashi H; Yoshida N; Nagashima M; Fujiwara T
    Jpn J Antibiot; 2013 Feb; 66(1):1-7. PubMed ID: 23777012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and multiple dose pharmacokinetics of dolutegravir in the genital tract of HIV-negative women.
    Adams JL; Patterson KB; Prince HM; Sykes C; Greener BN; Dumond JB; Kashuba AD
    Antivir Ther; 2013; 18(8):1005-13. PubMed ID: 23899439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults.
    Chien S; Bialer M; Solanki B; Verhaeghe T; Doose DR; Novak G; Yao C
    Epilepsia; 2006 Nov; 47(11):1830-40. PubMed ID: 17116022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
    Elliot ER; Cerrone M; Challenger E; Else L; Amara A; Bisdomini E; Khoo S; Owen A; Boffito M
    J Antimicrob Chemother; 2019 Jan; 74(1):149-156. PubMed ID: 30272231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.